Private Payrolls Rise 109000 in April Exceeding Expectations ADP Report Signals Stable Labor Market Hermeus Backed by Sam Altman and Peter Thiel Achieves Supersonic Flight Milestone Samir Arora Dismisses SIPs as Villain in Rupee Weakness Highlights Domestic Market Support Deere Company Raises FullYear Outlook Citing AIPowered Growth Lever in Precision Agriculture New York Bill Proposes Mandatory AI Job Impact Reporting Gen Z Price Sensitivity Fuels Discount Retail Growth for Walmart and Ross OCCIO Q1 2026 Earnings Significant EPS Miss Amid Challenging Credit Environment EPR Properties Q1 2026 Earnings EPS Surges Past Expectations Amid Strong Experiential Demand Bakkt Q1 2026 Earnings Significant EPS Miss Amid Ongoing Operational Challenges Lucid Diagnostics Inc Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Diagnostics Firm Advances Product Commercialization ORI Q1 2026 Earnings EPS Misses Estimates by 15 Stock Declines Slightly EXLS Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Pending Danaher DHR Slips Slightly Amid Broader Market Caution Key Support and Resistance Levels in Focus VirTra Inc VTSI Gains 235 as Shares Bounce From Key Support Level SR Bancorp Inc SRBK Holds Steady Near Support as Trading Volume Remains Modest IonQ IONQ Gains Ground as Quantum Computing Stock Approaches Key Resistance Greenwave Technology Solutions GWAV Slips 382 as Selling Pressure Tests Key Support Hardide Secures 24 Million Order from North American Energy Client CBNA Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Pullback Open Text OTEX Gains 108 as Stock Approaches Key Resistance Level SAMG Q1 2026 Earnings Earnings Miss as EPS Falls Short of Estimates ALAR Q4 2025 Earnings A Surprising EPS Beat Drives Positive Market Reaction SOWG Q3 2025 Earnings Significant EPS Miss Amid Challenging Quarter Fossil Group FOSL Q1 2026 Earnings EPS Beat on Lower Loss Amid Continued Market Challenges OZKAP Q1 2026 Earnings Marginal EPS Miss Amid Stable Performance NTB Q1 2026 Earnings Strong EPS Beat Amid Quiet Revenue Disclosure Stock Edges Lower Grace Therapeutics Q1 2026 Earnings EPS Surprise of 5098 Despite No Revenue as Stock Declines